Edmonton Obesity Staging System (EOSS)
The Edmonton Obesity Staging System, or EOSS, is a way for doctors to grade obesity based on how it affects your health and daily life, rather than just your BMI.
Plain English
Patient-Friendly Explanation
The Edmonton Obesity Staging System, or EOSS, is a way of grading obesity by how much it is actually affecting a person's health — rather than by body weight alone. It sorts patients into five stages: stage 0 means obesity with no related medical, physical or psychological problems; stage 1 means a risk factor or mild symptom is present; stage 2 means established conditions such as type 2 diabetes, high blood pressure or sleep apnoea; stage 3 means significant organ damage or serious functional limitation; and stage 4 means severe, potentially end-stage complications. The point of the system is that two people with the same BMI can need very different treatment. Someone at stage 0 may benefit from lifestyle support and monitoring, while someone at stage 2 or 3 needs active medical treatment — which is why clinicians use EOSS to decide who should be treated more intensively, and why the scale alone never tells the full story.
Medical
Clinical Definition
The Edmonton Obesity Staging System (EOSS) is a clinical framework proposed by Sharma and Kushner that stages obesity according to comorbidity burden, functional status and psychological impact, rather than anthropometry alone. Stage 0 denotes obesity with no apparent obesity-related risk factors, physical symptoms or psychopathology; stage 1, the presence of obesity-related risk factors or mild symptoms (e.g. hypertension treated to target, impaired fasting glucose); stage 2, established obesity-related comorbidities requiring active management (type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, osteoarthritis); stage 3, significant end-organ damage or marked functional limitation (e.g. myocardial infarction, heart failure, diabetic complications); and stage 4, severe disabling or end-stage complications. EOSS has been shown to predict all-cause mortality independently of BMI and metabolic syndrome, and is used to triage treatment intensity — from lifestyle counselling at low stages through to pharmacotherapy and bariatric surgery consideration at higher stages. It is a key argument for assessment-based rather than BMI-based treatment decisions.
Key Insight
Why It Matters
EOSS explains why a doctor asks far more questions than 'what do you weigh?'. Two patients with a BMI of 32 — one with normal blood pressure and no symptoms, another with pre-diabetes, poor sleep and knee pain — are clinically different problems with different treatment plans. This is the framework behind the assessment-first approach: the staging determines whether a person needs monitoring, structured lifestyle support, medical treatment or referral — and it is exactly why a responsible clinic will not sell a programme before understanding your stage.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: August 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
